David Chang
SlowingNamed in filings at Nomad Capital PartnersOn the current fund
- Board seats filed
- 9
Named in filings at Nomad Capital PartnersOn the current fund
all filings on record
last 24 months
from a verified or cited source
| Long Bridge Medical | Medical devices | December 2025 | None on file |
| 1200 Pharma | Biotech & pharma | April 2024 | None on file |
| Momo Orchard Holdings | Food & agriculture | March 2023 | None on file |
| IconOVir Bio | Biotech & pharma | December 2020 | Nextech Viii Carry Scsp, Vida Ventures |
| VENTIVA | Robotics & hardware | March 2020 | None on file |
| Actifio | Enterprise software | August 2018 | Pillar VC |
| Allogene Therapeutics | Biotech & pharma | April 2018 | Vida Ventures |
| Momomilk | E-commerce & marketplaces | October 2017 | None on file |
| Ando Food | Consumer apps & internet | September 2016 | None on file |
The company and date are what the SEC filing shows, not a statement of investment thesis. A partner can sit on a board for reasons that say nothing about what their firm funds today. The sector is not a filing value: it is Lev’s own classification of each company, shown only when we found a specific, checkable source for it; otherwise it reads “Not yet classified.” “Also on the board from” names another tracked firm with a partner on the same board, both with a clean identity match. It is not a claim either firm led or co-led the round, and “None on file” means no other tracked firm’s partner shares this specific board seat, not that no one else invested. Sorted newest first by default; click a column to change it. Something wrong? Tell us.
Classified sectors of companies where filings name David Chang on the board, based on 9 filed seats with a verified or cited source.